Gyeongnam Pharmaceutical's Sales Reach 70.9 Billion Won Last Year, Up 58.3% YoY... "All-Time High"

[Asia Economy Reporter Jang Hyowon] Gyeongnam Pharmaceutical announced on the 22nd that it continued its growth trend by recording its best-ever performance last year with sales of 70.9 billion KRW and operating profit of 2.1 billion KRW.

Sales increased by 58.3% compared to the previous year, and operating profit turned positive compared to the previous year.

Gyeongnam Pharmaceutical explained that it achieved its best-ever performance by improving operating profit through sales growth of major products such as Lemona and Jahasaengryeok, increased sales of the new product Gyeol Collagen, and increased gross profit through sales growth and cost improvement.

Recently launching Gyeol Collagen & Mucin products and venturing into new business areas such as veterinary medicine and prescription drugs, Gyeongnam Pharmaceutical plans to actively invest in next-generation growth engines to increase sales.

A company official stated, "Not only Lemona and Jahasaengryeok but also the recently launched Gyeol Collagen & Mucin have shown good responses, contributing to sales growth and recording the best-ever performance. We will do our best to continue the growth trend by actively investing in new business areas such as the inner beauty market, veterinary medicine, and prescription drugs."